THIS IS A CONFIDENTIAL AND PRIVILEGED COMMUNICATION

PLEASE DISPOSE OF PAPER COPIES APPROPRIATELY
Printed by:

Nam—

Test Name: F/S PLEURA{PLEURA
Ordered By:

UUID: 476705A9- 9092- 4852- 8294- -8CA7807R68e8BEa
H TCGA- -MQ-ASBQ -91A- -PR

I IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIICIIwd
Il

IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII

Age:
Test Date:

2640 o 3 Was

COLLECTION DATE: =7,“ 2 :01 Ed. @911 a 04W
SPECIMEN NUMBER:_ 9‘85 52/3

SPECIMENS:
1. FIS PLEURA
2. PLEURA

DIAGNOSIS:

1. PLEURA, BIOPSY:
- MALIGNANT MESOTHELIOMA, EPITHELIAL TYPE (SEE COMMENT)
- NON-NECROTIZING GRANULOMATOUS INFLAMMATION

2. PLEURA, BIOPSY:
- MALIGNANT MESOTHELIOMA, EPITHELIAL TYPE (SEE COMMENT)
- NON-NEGROTIZING GRANULOMATOUS INFLAMMATION

Comment: The immunostains show the tumor cells to be diffusely
positive for calretinin, WT-1 and CK5I6 and focally positive for
D240, supporting the diagnosis. The AFB and GMS are negative for
microorganisms.

Pathologist

CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS:
Pleural tumor

MACROSCOPIC DESCRIPTION:
The specimen is received in two parts each labeled with the
patient's name.

1. Part one is received fresh labeled 'pIeura for frozen section'.

It consists of four fragments of pink-yellow ﬁbrofatty tissue
measuring 0.5 x 0.6 x 0.4 cm, 1.2 x 0.8 x 0.3 cm, 0.9 x 0.9 x 0.4
cm, and 1 x 0.7 x 0.3 cm. Representative fragments are submitted
for tissue banking. A representative section is submitted for
frozen section diagnosis. The remainder is submitted in entirety.

2. Part two is received in saline labeled 'pIeura' and consists of
multiple pieces of pink-yellow rubbery tissue measuring 2 x 1 x 0.3
cm in aggregate. The specimen is submitted in entirety.

Si WHO?) 06934
CytOs/le/IE

. i
cm . ~
—€Ea%w- —.:521‘_13_ V2; No |
Dia~L_n-: ussr sDiscre pan y M-— t

Primal l\' 10! nor lit Di screpanr y_ ——~ I—i _. ‘1‘ f
_%__ .

HIPAA Di _-3_aepali cy I - ”ID—1""

9nnr Maliﬁninr y HISI-OFV _.
aI'

 

 

 

 
   

 

 

SUMMARY OF SECTIONS:

1A representative for frozen section diagnosis
18 remainder of specimen

2A in toto

SPECIAL PROCEDURES:
Calretinin, CK 5/6, WT1, 02-40
GMS, AFB

INTRA - OPERATIVE CONSULTATION:

1. Pleura, biopsy:
- Epithelioid tumor favor mesothelioma

Results reported by Dr. ' to Dr. in person at

Intra-Operative Consultation #1 performed by

Electronically signed
Final Diagnosis performed by

Electronically signed

The electronic signature attests that the named Attending
Pathologist has evaluated the specimen referred to in the signed
section of the report and formulated the diagnosis therein.

This report may include one or more immunohistochemical stain
results that use analyte speciﬁc reagents.

The tests were developed and their performance characteristics
determined by

They have not been cleared or approved by the US Food and Drug
Administration.

The FDA has determined that such clearance or approval is not
necessary.

